LALPATHLAB Share Price Target 2035

CAGR-based price projection for Dr. Lal Path Labs Ltd. (LALPATHLAB) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (17.1% CAGR)
Rs 8,299
2035 Target
Base Case (42.7% CAGR)
Rs 49,330
2035 Target
Bull Case (134.9% CAGR)
Rs 4,362,558
2035 Target

Current Market Snapshot

CMP: Rs 2,005.10
52W High: Rs 2,005.10
52W Low: Rs 1,367.20
1Y CAGR: 103.8%
3Y CAGR: 42.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 2,348 Rs 2,862 Rs 4,710
2028 Rs 2,749 Rs 4,085 Rs 11,062
2029 Rs 3,219 Rs 5,832 Rs 25,982
2030 Rs 3,770 Rs 8,324 Rs 61,026
2031 Rs 4,414 Rs 11,882 Rs 143,338
2032 Rs 5,169 Rs 16,961 Rs 336,671
2033 Rs 6,053 Rs 24,210 Rs 790,772
2034 Rs 7,088 Rs 34,559 Rs 1,857,360
2035 Rs 8,299 Rs 49,330 Rs 4,362,558

Other LALPATHLAB Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the LALPATHLAB share price target for 2035?

Based on historical growth analysis, the LALPATHLAB share price target for 2035 ranges from Rs 8,299 (conservative) to Rs 49,330 (base case) to Rs 4,362,558 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of LALPATHLAB?

The current market price of LALPATHLAB (Dr. Lal Path Labs Ltd.) is Rs 2,005.10. The 52-week high is Rs 2,005.10 and 52-week low is Rs 1,367.20.

Is LALPATHLAB a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for LALPATHLAB price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 17.1% CAGR), Base (42.7% CAGR), and Bull (optimistic at 134.9% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.